22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology

Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology

Core Clinical Mandate: Therapeutic contact lenses and orthokeratology represent specialized clinical applications where contact lenses transcend simple refractive correction to function as biological wound dressings, mechanical corneal shields, and active biomechanical remodeling devices. Certified Ophthalmic Medical Technologists (COMT) must master the material oxygen transmissibility ($Dk/t$) thresholds, epithelial healing kinetics, biological membrane biochemistries, and 4-zone reverse geometry fluidics essential for patient safety and clinical efficacy.

Therapeutic Bandage Contact Lenses (BCL)

A Therapeutic Bandage Contact Lens (BCL) is a soft contact lens applied to the cornea to relieve pain, promote re-epithelialization, maintain anatomical wound integrity, and shield the delicate ocular surface from mechanical eyelid trauma.

Material Criteria & The Holden-Mertz Oxygen Threshold

Historically, conventional poly-HEMA hydrogel lenses possessed low oxygen permeability ($Dk/t \approx 15\text{ to }30$), which caused severe corneal hypoxia, limbal engorgement, endothelial polymegethism, and microcystic edema when worn continuously overnight. Modern therapeutic practice mandates high-performance silicone hydrogel (SiHy) materials:

• Holden-Mertz Criterion for Extended Wear: Zero overnight hypoxia requires a minimum oxygen transmissibility ($Dk/t$) of 87 Fatt units. For an inflamed, compromised cornea, modern clinical consensus recommends a $Dk/t \ge 100\text{ to }125$.
• FDA-Approved Therapeutic SiHy Lenses:
  • Lotrafilcon A (Air Optix Night & Day): Exceptional oxygen transmissibility ($Dk/t = 175$), low water content (24%), rigid fluorosilicone structure resistant to protein buildup.
  • Balafilcon A (PureVision): High oxygen transmissibility ($Dk/t = 101$), surface-treated plasma oxidation.
  • Senofilcon A (Acuvue Oasys): High oxygen transmissibility ($Dk/t = 147$), internal polyvinylpyrrolidone (PVP) wetting agent, low modulus (0.72 MPa) maximizing comfort over irregular epithelial defects.

Clinical Indications & Mechanisms of Therapeutic BCLs

1. Pain Management in Bullous Keratopathy

• Pathophysiology: Endothelial decompensation (from Fuchs endothelial corneal dystrophy or cataract surgical trauma [pseudophakic bullous keratopathy]) causes chronic stromal over-hydration. Fluid breaks through Bowman's layer, elevating epithelial blisters (bullae). When these bullae rupture, naked subepithelial nerve endings are directly exposed to air and eyelid friction, producing excruciating pain, photophobia, and foreign body sensation.
• BCL Mechanism: The bandage lens covers the exposed corneal nerve plexus, acting as a synthetic epithelium that shields nerve terminals from the abrasive shear of the blinking upper lid, providing immediate pain relief.

2. Persistent Epithelial Defects (PED) & Post-Refractive Surgery (PRK/PTK)

• Pathophysiology: In neurotrophic keratopathy, diabetic keratopathy, chemical burns, or following Photorefractive Keratectomy (PRK), healing corneal epithelial cells migrate across the bare stroma. Repetitive blinking shears newly formed migratory cells, preventing closure.
• BCL Mechanism: Provides a stable mechanical roof beneath which migrating basal epithelial cells can advance, proliferate, and assemble stable basement membrane complexes.

3. Recurrent Corneal Erosion Syndrome (RCES)

• Pathophysiology: RCES stems from defective epithelial basement membrane anchoring complexes (e.g., in Epithelial Basement Membrane Dystrophy [EBMD / Map-Dot-Fingerprint] or following superficial traumatic fingernail/paper cuts). Newly synthesized basal cells fail to form anchoring fibrils and hemidesmosomes.
• The Nocturnal Shearing Cycle: During sleep, the cornea becomes mildly edematous and dehydrated tears adhere the loose epithelium to the dry tarsal conjunctiva. Upon abrupt morning eyelid opening, the adherent epithelium tears off the basement membrane, causing sudden severe pain and lacrimation.
• The 6-to-12 Week Rule: A therapeutic BCL must remain continuously in place for 6 to 12 weeks (with monthly lens replacement). It requires at least 8 to 12 weeks for basal epithelial cells to fully synthesize mature Type VII collagen anchoring fibrils and hemidesmosome attachment plaques. Premature removal at 1 to 2 weeks exposes fragile, unanchored epithelium to recurrent rupture.

4. Micro-perforations and Seidel-Positive Wound Leaks

• For small traumatic corneal punctures or focal wound dehiscence (< 1 mm) with a trace Seidel-positive aqueous leak, a tight-fitting SiHy BCL (often combined with topical cyanoacrylate tissue adhesive) tamponades fluid egress, allowing anterior chamber reformation.

Clinical Management Protocol for Bandage Lenses

• Antimicrobial Prophylaxis: Because continuous wear under a compromised ocular surface poses a high risk of bacterial keratitis, all BCL patients must receive prophylactic broad-spectrum topical fluoroquinolones (e.g., moxifloxacin 0.5% or gatifloxacin 0.5% qid) without preservatives while the lens is in place.
• Fit Criteria: The lens must exhibit slight movement (0.25 to 0.50 mm on blink and push-up). A totally immobile, tight lens traps inflammatory debris and dead cellular waste beneath the optic, precipitating corneal ulceration.

Biological Tissue Dressings: Amniotic Membrane Transplantation (AMT)

Amniotic membrane is harvested from the innermost placental layer of screened donors undergoing elective Cesarean section. It comprises a thick collagenous basement membrane and an avascular stromal matrix rich in bioactive molecules.

Biochemical Mechanisms of Amniotic Tissue

1. Anti-Inflammatory Action: Contains high concentrations of heavy chain-hyaluronan/pentraxin 3 (HC-HA/PTX3) complexes that selectively induce apoptosis in activated inflammatory macrophages and suppress neutrophil infiltration.
2. Inhibition of Corneal Scarring: Directly downregulates Transforming Growth Factor-beta (TGF-$\beta$) signaling pathways, preventing the transformation of quiescent keratocytes into contractile myofibroblasts, thereby eliminating stromal haze and fibrotic scarring.
3. Anti-Angiogenic Factors: Expresses endostatin, thrombospondin-1, and tissue inhibitors of metalloproteinases (TIMPs), suppressing pathological corneal neovascularization.
4. Neurotrophic Support: Releases nerve growth factor (NGF) and epidermal growth factor (EGF) that accelerate corneal nerve regeneration and re-epithelialization.

Cryopreserved vs. Dehydrated Amniotic Membranes

Orthokeratology (Ortho-K) Mechanics & Corneal Remodeling

Orthokeratology (Ortho-K) involves the nocturnal wear of specialized rigid gas permeable (RGP) contact lenses that intentionally reshape the anterior corneal curvature during sleep, eliminating refractive myopia and astigmatism throughout waking hours without spectacles or contact lenses.

Cellular Remodeling vs. Corneal Bending

Histological and high-resolution anterior segment OCT studies confirm that Ortho-K does not bend the entire cornea, nor does it compress the stroma:

• Epithelial Redistribution: The central corneal epithelium thins by 10 to 20 µm (approximately 1 to 2 cell layers) due to the compression and lateral redistribution of superficial and wing epithelial cells.
• Mid-Peripheral Thickening: Simultaneously, the mid-peripheral corneal epithelium and anterior stroma thicken by 10 to 15 µm as displaced cellular fluid and intracellular glycogen accumulate in the mid-periphery.
• Endothelial & Stromal Safety: The corneal endothelium, posterior stroma, and total keratocyte counts remain completely unharmed when high-$Dk$ materials ($Dk > 100$, such as Boston XO or Menicon Z) are utilized.

Reverse Geometry 4-Zone Lens Architecture

Standard RGP lenses have a base curve that is steeper centrally and flattens toward the periphery. Ortho-K utilizes a reverse geometry design, where the lens is flatter centrally and steeper in the mid-periphery:

1. Base Curve (Treatment Curve):
   • Sits over the central 5.0 to 6.0 mm of the cornea.
   • Designed flatter than the central flat keratometry ($K$) reading by the exact amount of myopia to be corrected, plus an additional empirical +0.75 D to +1.00 D "Jessen factor" (overcorrection factor to ensure clear vision persists until the end of the day).
   • Generates positive hydrostatic squeezing forces within the ultra-thin central tear film (~5 µm thickness), pushing fluid and epithelial cells outward.
2. Reverse Curve:
   • An annular ring (0.5 to 1.0 mm wide) engineered significantly steeper (3.00 to 10.00 D steeper) than the adjacent base curve.
   • Creates a localized deep tear reservoir (~50 to 60 µm deep) that generates negative hydrostatic suction (pulling forces), drawing displaced epithelial fluid and tissue into the mid-periphery.
3. Alignment (Landing / Fitting) Curve:
   • Sits in the peripheral cornea (typically matching a 35° to 45° tangential angle).
   • Aligns precisely with the peripheral corneal contour to stabilize lens centration, bear the physical load of the lens, and form a tight fluid seal that isolates the reverse curve suction gutter.
4. Peripheral Curve:
   • The outermost edge curve, flatter than the alignment curve.
   • Provides an edge clearance lift of 70 to 100 µm, allowing tear exchange and preventing peripheral edge binding during sleep.

Optical Physics of Pediatric Myopia Control & Infectious Risks

Beyond temporary daytime refractive correction in adults, the primary modern clinical application of orthokeratology is slowing axial eye elongation in children with progressive myopia.

Peripheral Defocus Theory

• The Flaw of Standard Spectacles (Peripheral Hyperopic Defocus): The normal human eye is non-spherical; its prolate retinal contour curves forward in the periphery. When a myopic child wears standard single-vision spectacle lenses, central light rays focus sharply on the fovea, but peripheral rays focus behind the peripheral retina (hyperopic peripheral defocus). This hyperopic blur is the primary biological stimulus triggering scleral matrix metalloproteinase synthesis, scleral thinning, and rapid axial elongation of the eyeball.
• Ortho-K Myopia Control (Peripheral Myopic Defocus): By flattening the central cornea (correcting central myopia) and simultaneously steepening the mid-periphery, the Ortho-K cornea acts as a multifocal surface. Peripheral light rays are bent more strongly, causing them to focus in front of the peripheral retina (myopic peripheral defocus). This myopic defocus acts as an absolute stop signal, slowing axial elongation by 40% to 60% compared to single-vision spectacles or contact lenses.

Retinal Defocus Comparison in Myopic Progression:

Standard Single-Vision Glasses:       Ortho-K Corneal Remodeling:
       Retina Profile                        Retina Profile
          ┌───┐                                 ┌───┐
          │   │                                 │   │
───────►  │ • │ Foveal Focus (Emmetropic)───►   │ • │ Foveal Focus (Emmetropic)
          │   │                                 │   │
  ───────►└───┼───► Peripheral Rays     ───────►│*  └───► Peripheral Rays Focused
              │     Behind Retina!              │     IN FRONT OF Retina!
              │     (HYPEROPIC DEFOCUS)         │     (MYOPIC DEFOCUS = STOP SIGNAL)
              ▼                                 ▼
   [Stimulates Scleral Growth]         [Halts Axial Elongation ~50%]

The Serious Infectious Threat: Acanthamoeba and Pseudomonas

Because Ortho-K requires closed-eye nocturnal wear, it carries a substantially elevated risk of severe microbial keratitis compared to daily wear lenses:

• Incidence: Estimated at 7.7 to 13.9 per 10,000 patient-years in pediatric cohorts—comparable to or higher than adult soft extended wear.
• Pathogen Predilection: Disproportionately high incidence of Pseudomonas aeruginosa and Acanthamoeba keratitis.
• Etiology: Epithelial micro-abrasions from rigid lens insertion, closed-eye nocturnal hypoxia, and frequent patient/parent non-compliance (e.g., washing lens cases with tap water, swimming with lenses, using saliva or expired solutions).
• COMT Emergency Mandate: Any Ortho-K patient presenting with pain, redness, or discharge must be treated as an acute infectious keratitis emergency until proven otherwise. Immediately discontinue lens wear, perform slit-lamp examination with fluorescein, and never prescribe topical steroids without corneal specialist oversight.

Cosmetic & Prosthetic Contact Lenses

The COMT column of the blueprint lists specialty lenses for cosmetic/prosthetics alongside irregular cornea, post-transplant, keratoconus and bandage designs. These are therapeutic devices, not novelty lenses, and the fitting priorities differ from every other lens in this chapter because the target is appearance and light control rather than acuity.

Prosthetic Lenses for the Disfigured Eye

A prosthetic contact lens is used when the globe is intact but disfigured — a leucomatous corneal scar, a phthisical-looking eye with corneal opacity, aniridia after trauma, or a blind white eye. The lens carries a hand-painted or laser-printed iris pattern matched to the fellow eye, with an opaque black backing layer behind the pupil so ambient light does not wash the printed iris out and the pupil reads as genuinely dark.

Distinguish this clearly from an ocular prosthesis (an artificial eye), which is fitted by an ocularist over an eviscerated or enucleated socket. A prosthetic contact lens presupposes a globe to sit on.

Fitting priorities that reverse the usual rules:

• Minimal movement is the goal. A well-centred, low-movement fit keeps the painted pupil aligned with the patient's own; the 0.5 to 1.0 mm of movement you would want in a routine soft lens makes the eye look wrong on every blink.
• Match the fellow eye in ambient room light, not under the slit lamp, and check the match at conversational distance rather than at the biomicroscope.
• Pupil diameter is fixed. The painted pupil cannot dilate, so choose a diameter that is a reasonable compromise between the fellow eye's photopic and mesopic sizes.
• Counsel explicitly that vision is not restored. The opaque pupil usually reduces what little vision the eye has. Patients who expect an optical benefit are reliably disappointed.

Occluder & Light-Control Lenses

The same technology solves two functional problems:

• Intractable diplopia. An opaque black-pupil occluder lens on the non-dominant eye eliminates the second image when prism cannot fuse it and patching is cosmetically unacceptable. It is also used for occlusion therapy in amblyopia when a child defeats adhesive patches.
• Glare and photophobia from a damaged or absent iris. In aniridia, albinism, traumatic mydriasis or a large iridectomy, a tinted lens with a clear central aperture in an otherwise opaque iris pattern creates an artificial pupil, cutting stray light while preserving the visual axis. Choosing the aperture diameter is the whole fitting: too small and the patient loses field and light in dim conditions, too large and the photophobia persists.

Handling and hygiene counselling is stricter than for a routine lens, because these lenses are custom, expensive and slow to replace: no abrasive cleaners on a painted surface, no tap water, and a spare lens or spectacle plan for the days the lens is out.